MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Industry news

Related news

Latest News

Phase Forward Signs Multi-Year Agreement with Quotient Clinical for Use of InForm(TM) Electronic Data Capture Solution
Scientists Launch Effort to Sequence the DNA of 10,000 Vertebrates
Phase Forward Announces Share Repurchase Program
AtriCure Reports Third Quarter 2009 Financial Results
Osiris Therapeutics Reports Third Quarter 2009 Financial Results
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update
OraSure Announces 2009 Third Quarter Financial Results
Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
Ortho Clinical Diagnostics Launches First-of-its-kind Remote Monitoring Center 24 Hour Central Command Center now Offers Predictive and Proactive Diagnostic Monitoring Service in Eight Languages to Clinical Laboratories in 18 Countries Using VITROS
InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
More news... | RSS Feed...

Most Viewed

VAXIN LAUNCHES JOINT VENTURE WITH ANC BIO IN KOREA

Plexxikon Treats Initial Patient With First-in-Class Drug in Phase 1 Trial

Biovail Provides Update on Pimavanserin Collaborative Development Program

Positive phase II results for GSK1838262 (XP13512) reported for subjects with post-herpetic neuralgia and a history of inadequate response to gabapentin

KIMBERLY-CLARK ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE I-FLOW CORPORATION

Therapeutic Target

Cardiovascular
Dermatology
Endocrine and Metabolic
Gastroenterology
Genitourinary
Hematology
Immunology and Allergy
Infection
Musculoskeletal
Neurology
Obstetrics and Gynecology
Oncology
Ophthalmology
Psychiatry
Pulmonary

Categories

Deals and Alliances
Development
Financial Results
Financings
Intellectual Property
Regulatory
Press releases
Deals review
Headlines
PR Newswire

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
PharmaVenue
Stem Cell USA
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us